dimethyl sulfoxide has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 2 studies
Dimethyl Sulfoxide: A highly polar organic liquid, that is used widely as a chemical solvent. Because of its ability to penetrate biological membranes, it is used as a vehicle for topical application of pharmaceuticals. It is also used to protect tissue during CRYOPRESERVATION. Dimethyl sulfoxide shows a range of pharmacological activity including analgesia and anti-inflammation.
dimethyl sulfoxide : A 2-carbon sulfoxide in which the sulfur atom has two methyl substituents.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Silvestri, S | 1 |
| Cirilli, I | 1 |
| Marcheggiani, F | 1 |
| Dludla, P | 1 |
| Lupidi, G | 1 |
| Pettinari, R | 1 |
| Marchetti, F | 1 |
| Di Nicola, C | 1 |
| Falcioni, G | 1 |
| Marchini, C | 1 |
| Orlando, P | 1 |
| Tiano, L | 1 |
| Amici, A | 1 |
| Chapman, MP | 1 |
| Risom, T | 1 |
| Aswani, AJ | 1 |
| Langer, EM | 1 |
| Sears, RC | 1 |
| Tomlin, CJ | 1 |
2 other studies available for dimethyl sulfoxide and ER-Negative PR-Negative HER2-Negative Breast Cancer
| Article | Year |
|---|---|
Evaluation of anticancer role of a novel ruthenium(II)-based compound compared with NAMI-A and cisplatin in impairing mitochondrial functionality and promoting oxidative stress in triple negative breast cancer models.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cisplatin; Dimethyl Sulf | 2021 |
Modeling differentiation-state transitions linked to therapeutic escape in triple-negative breast cancer.
Topics: Antineoplastic Agents; Biomarkers, Tumor; Cell Death; Cell Differentiation; Cell Division; Cell Line | 2019 |